Lucid Diagnostics Net Income 2021-2024 | LUCD
Lucid Diagnostics net income from 2021 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Lucid Diagnostics Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-53 |
| 2023 | $-53 |
| 2022 | $-56 |
| 2021 | $-28 |
| 2020 | $-8 |
| Lucid Diagnostics Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-12 |
| 2024-09-30 | $-12 |
| 2024-06-30 | $-11 |
| 2024-03-31 | $-18 |
| 2023-12-31 | $-11 |
| 2023-09-30 | $-14 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-15 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-15 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-11 |
| 2021-09-30 | $-7 |
| 2021-06-30 | $-6 |
| 2021-03-31 | $-4 |
| 2020-12-31 | |
| 2020-09-30 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.136B | $0.004B |
| Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK. | |||